Sakti Chakrabarti

University Hospitals Seidman Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (4)

Sulin Wu

University of California, Los Angeles

UNITED STATES

View details

Amit Mahipal

University Hospitals Seidman Cancer Center

UNITED STATES

View details

Sylvia L. Asa

University Health Network

CANADA

View details

Christopher W. Towe

University Hospitals Cleveland Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Sakti Chakrabarti

Research Interests

Explore related searches

Contact this professor

Articles (10)

Circulating Tumor DNA Testing for Minimal Residual Disease and Its Application in Colorectal Cancer

Toxicity Associated with Pembrolizumab Monotherapy in Patients with Gastrointestinal Cancers: A Systematic Review of Clinical Trials

Outcome of Patients with Locally Advanced Rectal Cancer Pursuing Non-Surgical Strategy in National Cancer Database

Frequency of Common and Uncommon BRAF Alterations among Colorectal and Non-Colorectal Gastrointestinal Malignancies

Circulating Tumor DNA as a Minimal Residual Disease Assessment and Recurrence Risk in Patients Undergoing Curative-Intent Resection with or without Adjuvant Chemotherapy in Colorectal Cancer: A Systematic Review and Meta-Analysis

A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data

Circulating tumor DNA-guided minimal residual disease assessment in colorectal cancer

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma

The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines

Collaborators (4)

Sulin Wu

Amit Mahipal

Sylvia L. Asa

Christopher W. Towe

Make your next move.